Seeking Alpha

  Pozen, Inc. - NASDAQ

10/24/2014, 4:31 PM ET
  • Roy Manning III | Send Message 17 Mar 2012

    POZN has $7 a share potential with Ulcer free aspirin study ending in march. Low cash burn since studies are over - $110m in cash.
      POZN vs. ETF Alternatives
      Company Description
      POZEN Inc is a pharmaceutical company engaged in developing innovative products that address unmet medical needs in the marketplace.